Certara Services Archives

Publication

针对复发难治性（R/R）骨髓纤维化（MF）及其他髓系或实体瘤恶性肿瘤患者的 Navtemadlin 群体药代动力学与药效学分析

This study conducted a population pharmacokinetic (PK) and pharmacodynamic (PD) analysis of navtemadlin, an MDM2…

Certara2025 年 2 月 6 日

Press Coverage

2025 cell and gene challenges: Scalability, supply chain and manufacturing

Explore insights on 2025 challenges in cell and gene therapy, including commercial viability, with expert…

Certara2025 年 2 月 3 日

Blog

国际医药内容推广的最佳实践

2025 年 1 月 31 日 Pharmaceutical market access, sales, and field teams rely on high-quality, effective content…

Certara2025 年 1 月 31 日

新闻报导

How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?

Discover how advances in personalized medicine are reshaping patient care, and why biosimulation will become…

Certara2025 年 1 月 31 日

On-Demand Webinar

转变视角：药物相互作用 PBPK 建模 25 年

Vice President and Head of Global PK/PD and Pharmacometrics at Eli Lilly and Company Dr.…

Certara2025 年 1 月 29 日

Press Coverage

What 2025 could bring for psychedelic use in healthcare

Explore the evolving landscape of psychedelic medicine, featuring updates from key players and insights on…

Certara2025 年 1 月 13 日

On-Demand Webinar

利用基于模型的荟萃分析 (MBMA) 解决药物开发难题

In this on-demand webinar, "MBMA: Optimizing Drug Development with Aggregate Clinical Trial Data and Predictive…

Certara2025 年 1 月 9 日

Publication

INTERCEPT-AD：一项针对阿尔茨海默病所致轻度认知障碍或轻度痴呆患者的静脉注射 Sabirnetug 的 I 期研究

The Phase 1 INTERCEPT-AD study evaluated sabirnetug (ACU193), a monoclonal antibody targeting amyloid-beta oligomers (AβOs),…

Certara2025 年 1 月 8 日

On-Demand Webinar

从何入手？利用 GenAI 让您的医学撰写团队取得成功

Generative AI (GenAI) is poised to revolutionize writing and report generation. In fact, industry studies…

Certara2025 年 1 月 6 日

Press Coverage

Pharma – 2025 Health IT Predictions

Discover transformative 2025 Health IT predictions, from AI in drug discovery to personalized medicine and…

Certara2025 年 1 月 3 日

Certara 服务

针对复发难治性（R/R）骨髓纤维化（MF）及其他髓系或实体瘤恶性肿瘤患者的 Navtemadlin 群体药代动力学与药效学分析

2025 cell and gene challenges: Scalability, supply chain and manufacturing

国际医药内容推广的最佳实践

How do you see advances in personalized medicine reshaping patient care, and what are the key challenges and opportunities ahead?

转变视角：药物相互作用 PBPK 建模 25 年

What 2025 could bring for psychedelic use in healthcare

利用基于模型的荟萃分析 (MBMA) 解决药物开发难题

INTERCEPT-AD：一项针对阿尔茨海默病所致轻度认知障碍或轻度痴呆患者的静脉注射 Sabirnetug 的 I 期研究

从何入手？利用 GenAI 让您的医学撰写团队取得成功

Pharma – 2025 Health IT Predictions

订阅时事通讯

快捷链接

解决方案

联系我们